Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Valion Bio (TIVC) Interest & Investment Income (2024 - 2025)

Valion Bio has reported Interest & Investment Income over the past 2 years, most recently at -$4000.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 140.0% year-over-year to -$4000.0; the TTM value through Dec 2025 reached $10000.0, changed N/A, while the annual FY2025 figure was $7000.0, 30.0% down from the prior year.
  • Interest & Investment Income for Q4 2025 was -$4000.0 at Valion Bio, down from $4000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $10000.0 in Q4 2024 and troughed at -$4000.0 in Q4 2025.